14th Orange County Symposium for Cardiovascular Disease Prevention

14th Orange County Symposium for Cardiovascular Disease Prevention is organized by the University of California, Irvine (UCI) School of Medicine and will be held from Mar 24, 2016 - Oct 30, 2022, at DoubleTree By Hilton Hotel Anaheim - Orange County, Orange, California, United States of America. This course has been approved for a maximum of 6 Credits.

Live - External Activity is Available From:
Release Date: 03/24/2016
Expiration Date: 10/30/2022

Description:
Coronary Heart Disease (CHD) is the leading cause of death in the United States and accounts for about 1 in 6 deaths annually. It has been estimated that nearly one-half of all middle-aged men and one-third of all middle-aged women in the United States will develop some index of CHD. Since 1975, CVD mortality has declined by 24 to 28 percent overall, among men and women, as well as blacks and whites, although men and blacks continue to experience far higher mortality rates at earlier ages than their female and white counterparts, respectively. Since 1990, however, the rate of decline in CVD mortality has slowed. It has been estimated that half of the decline is due to earlier diagnosis and more aggressive treatment, particularly with adjuvant drug therapies. The remaining half of the decline in CVD mortality is attributable to favorable changes in risk factors, such as the decline in cigarette smoking and the aggressive management of lipids and blood pressure. Contemporary studies now suggest that behavior change and multifactorial risk factor modifications especially smoking cessation and more intensive measures to control hyperlipidemia with diet, drugs, and exercise may slow, halt, or even reverse the progression of atherosclerotic CHD.

Objectives:
• Discuss the importance of aggressive LDL-C Reduction in Acute Coronary Syndrome
• Discuss the connection between the Heart and Brain and Novel Integrative Approaches to Care
• Discuss the role of Non-Alcoholic Fatty Liver Disease and Cardiovascular Health
• Discuss Sex Differences in the Prevention of Heart Failure
• Discuss the role of Lipoprotein(a) as an Underappreciated Genetic Factor and Emerging
• Discuss the role of Hypertriglyceridemia, Remnants, and Cardiovascular Disease
• Discuss Multispecialty Practice Recommendations for the Management of Diabetes, CardioRenal, and Metabolic Diseases
• Discuss the Aging Heart and the Role of lifestyle, inflammation, and other factors
• Discuss what are the optimal diets for the prevention of cardiovascular disease
• Discuss Evidence-based Supplements and CV Health
• Discuss the role of psychosocial factors and stress in cardiovascular disease
Additional details will be posted as soon as information is available.